Literature DB >> 20504136

Volume of prescription opioids used nonmedically in the United States.

Nathaniel P Katz1, Howard G Birnbaum, Adam Castor.   

Abstract

ABSTRACT To understand the magnitude of prescription opioid abuse in the United States, it is critical to determine how many dosage units of prescription opioids are ingested nonmedically per year. Using several public and private databases, the authors estimated that in 2002-2003, among the 10.89 million individuals projected to have used prescription opioids nonmedically, a minimum of 430.61 million doses were used nonmedically per year (assuming only one dose consumed per nonmedical use per day per individual). This represented about 1/25 of all prescription opioid doses dispensed. This estimate provides a perspective on the magnitude of prescription opioids abuse and should help policy makers enact policies that reduce prescription opioid abuse and diversion without preventing legitimate access to opioid therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504136     DOI: 10.3109/15360281003799098

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  8 in total

1.  Opioids for chronic pain: first do no harm.

Authors:  Roger A Rosenblatt; Mary Catlin
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

Review 2.  Severe chronic pain following spinal cord damage: a pragmatic perspective for prescribing opioids.

Authors:  Peter Wayne New
Journal:  Spinal Cord Ser Cases       Date:  2018-07-27

3.  Leftover prescription opioids and nonmedical use among high school seniors: a multi-cohort national study.

Authors:  Sean Esteban McCabe; Brady T West; Carol J Boyd
Journal:  J Adolesc Health       Date:  2012-11-22       Impact factor: 5.012

4.  Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Pragmatic Effectiveness Trial of a Nonpharmacologic Alternative for the Treatment of Postoperative Pain.

Authors:  Brian M Ilfeld; Harold Gelfand; Sandeep Dhanjal; Robert Hackworth; Anthony Plunkett; Alparslan Turan; Alice M Vijjeswarapu; Steven P Cohen; James C Eisenach; Scott Griffith; Steven Hanling; Edward J Mascha; Daniel I Sessler
Journal:  Pain Med       Date:  2020-12-12       Impact factor: 3.750

Review 5.  Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics.

Authors:  Teresa D Schmidt; J David Haddox; Alexandra E Nielsen; Wayne Wakeland; John Fitzgerald
Journal:  J Behav Health Serv Res       Date:  2015-10       Impact factor: 1.505

6.  Information on doctor and pharmacy shopping for opioids adds little to the identification of presumptive opioid abuse disorders in health insurance claims data.

Authors:  Alexander M Walker; Lisa B Weatherby; M Soledad Cepeda; Daniel C Bradford
Journal:  Subst Abuse Rehabil       Date:  2019-08-01

7.  Opioid prescription patterns among patients who doctor shop; Implications for providers.

Authors:  Todd Schneberk; Brian Raffetto; Joseph Friedman; Andrew Wilson; David Kim; David L Schriger
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

8.  The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy.

Authors:  Jeffrey A Gudin
Journal:  Ther Clin Risk Manag       Date:  2012-05-01       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.